ES2096329T3 - Procedimiento para la preparacion de derivados del taxano. - Google Patents

Procedimiento para la preparacion de derivados del taxano.

Info

Publication number
ES2096329T3
ES2096329T3 ES93921983T ES93921983T ES2096329T3 ES 2096329 T3 ES2096329 T3 ES 2096329T3 ES 93921983 T ES93921983 T ES 93921983T ES 93921983 T ES93921983 T ES 93921983T ES 2096329 T3 ES2096329 T3 ES 2096329T3
Authority
ES
Spain
Prior art keywords
preparation
taxane derivatives
procedure
bacatine
vii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93921983T
Other languages
English (en)
Inventor
Alain Commercon
Eric Didier
Elie Fouque
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9434120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2096329(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Application granted granted Critical
Publication of ES2096329T3 publication Critical patent/ES2096329T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCESO DE PREPARACION DE DERIVADOS DE TAXANO DE FORMULA GENERAL (I) POR ESTERIFICACION DE LA BACATINA III O DE LA DESACETIL-10 BACATINA III PROTEGIDA MEDIANTE UN ACIDO DE FORMULA GENERAL (VII), DEPROTEC DE LA CADENA LATERAL Y ELIMINACION DE LOS GRUPOS PROTECTORES DE LAS FUNCIONES HIDROXI. EN LAS FORMULAS (I) Y (VII): AR REPRESENTA ARILO, R REPRESENTA HIDROGENO O ACETILO, R1 REPRESENTA BENZOILO O R2-O-CO EN EL QUE R2 REPRESENTA ALCOILO, ALCENILO, ALCINILO, CICLOALCOILO, CICLOALCENILO, BICILOALCOILO, FENILO O HETEROCICLILO, R3 REPRESENTA HIDROGENO, ALCOXI, ARIL EVENTUALMENTE SUSTITUIDO.
ES93921983T 1992-10-05 1993-10-04 Procedimiento para la preparacion de derivados del taxano. Expired - Lifetime ES2096329T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211742A FR2696459B1 (fr) 1992-10-05 1992-10-05 Procédé de préparation de dérivés du taxane.

Publications (1)

Publication Number Publication Date
ES2096329T3 true ES2096329T3 (es) 1997-03-01

Family

ID=9434120

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93921983T Expired - Lifetime ES2096329T3 (es) 1992-10-05 1993-10-04 Procedimiento para la preparacion de derivados del taxano.

Country Status (31)

Country Link
US (1) US5637723A (es)
EP (1) EP0663907B1 (es)
JP (1) JP3014761B2 (es)
KR (1) KR100297197B1 (es)
CN (1) CN1048983C (es)
AT (1) ATE147735T1 (es)
AU (1) AU689081B2 (es)
CA (1) CA2146155C (es)
CZ (1) CZ283362B6 (es)
DE (1) DE69307527T2 (es)
DK (1) DK0663907T3 (es)
EE (1) EE03125B1 (es)
ES (1) ES2096329T3 (es)
FI (1) FI109791B (es)
FR (1) FR2696459B1 (es)
GE (1) GEP19981299B (es)
GR (1) GR3022285T3 (es)
HU (1) HU223775B1 (es)
LT (1) LT3439B (es)
LV (1) LV10858B (es)
MX (1) MX9305767A (es)
NO (1) NO310412B1 (es)
NZ (1) NZ256446A (es)
PL (1) PL179147B1 (es)
RU (1) RU2116302C1 (es)
SG (1) SG63619A1 (es)
SK (1) SK280624B6 (es)
TW (1) TW262471B (es)
UA (1) UA43835C2 (es)
WO (1) WO1994007878A1 (es)
ZA (1) ZA937319B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2697522B1 (fr) * 1992-10-30 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
FR2698361B1 (fr) * 1992-11-20 1995-01-13 Rhone Poulenc Rorer Sa Procédé de préparation d'un acide oxazolidine-1,3 carboxylique-5.
FR2698871B1 (fr) 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
MX9307777A (es) 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
EP0982302B1 (en) * 1993-06-11 2004-04-14 PHARMACIA & UPJOHN COMPANY Delta 6,7-taxols antineoplastic use and pharmaceutical compositions containing them
FR2706457B1 (fr) * 1993-06-16 1995-07-28 Rhone Poulenc Rorer Sa Procédé de préparation d'un acide oxazolidinecarboxylique utile pour préparer des taxoïdes thérapeutiquement actifs.
IL127599A (en) * 1994-01-28 2004-06-01 Upjohn Co Process for preparing isotaxol analogs
CA2170661A1 (en) * 1995-03-22 1996-09-23 John K. Thottathil Novel methods for the preparation of taxanes using oaxzolidine intermediates
MA23823A1 (fr) 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US6372780B2 (en) 1995-03-27 2002-04-16 Aventis Pharma S.A. Methods of treating cell lines expressing multidrug resistance P-glycoprotein
US5847170A (en) * 1995-03-27 1998-12-08 Rhone-Poulenc Rorer, S.A. Taxoids, their preparation and pharmaceutical compositions containing them
EP0868422A1 (de) * 1996-09-24 1998-10-07 Marigen S.A. Ultramikroemulsionen aus spontan dispergierbaren konzentraten mit antitumoral und antiviral wirksamen estern von baccatin-iii-verbindungen
FR2771092B1 (fr) * 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
US6096250A (en) * 1998-03-06 2000-08-01 Caesar International, Inc. Process for releasing a runner from an electronic device package on a laminate plate
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
US6346543B1 (en) 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6403634B1 (en) 1999-01-13 2002-06-11 Aventis Pharma S.A. Use of taxoid derivatives
IT1308636B1 (it) * 1999-03-02 2002-01-09 Indena Spa Procedimento per la preparazione di tassani da 10-desacetilbaccatinaiii.
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2002066448A1 (en) * 2001-02-20 2002-08-29 Dabur India Limited Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid
DE01924282T1 (de) * 2001-03-23 2007-04-19 Scinopharm Taiwan, Ltd. Verfahren zur herstellung von taxanderivaten
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
FR2882362B1 (fr) * 2005-02-23 2007-05-11 Seripharm Procede de preparation du paclitaxel
JP2010506932A (ja) * 2006-10-20 2010-03-04 シノファーム シンガポール ピーティーイー，リミテッド 結晶性の無水ドセタキセルの製造方法
PL210984B1 (pl) * 2006-10-31 2012-03-30 Inst Farmaceutyczny Sposób wytwarzania docetakselu
KR100847331B1 (ko) * 2006-12-14 2008-07-21 한미약품 주식회사 도세탁셀의 제조방법 및 이에 사용되는 중간체
KR100921036B1 (ko) 2006-12-18 2009-10-08 한미약품 주식회사 탁산유도체의 제조방법 및 이에 사용되는 중간체
US8637466B2 (en) 2008-08-11 2014-01-28 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
WO2011134067A1 (en) * 2010-04-29 2011-11-03 6570763 Canada Inc. Novel amino acid molecule and uses thereof
US10894087B2 (en) 2010-12-22 2021-01-19 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
US20130338216A1 (en) 2010-12-22 2013-12-19 Nektar Therapeutics Deuterated and/or fluorinated taxane derivatives
US20130331443A1 (en) 2010-12-22 2013-12-12 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
ES2712804T3 (es) 2011-09-26 2019-05-14 Fresenius Kabi Oncology Ltd Procedimientos para la preparación de carbazitaxel que implican la sililación en C(7)-OH y C(13)-OH o solo la sililación en C(7)-OH
KR101379694B1 (ko) * 2011-09-30 2014-03-31 주식회사 삼양바이오팜 탁산유도체의 제조방법
CN102382080B (zh) * 2011-12-15 2014-06-18 扬子江药业集团江苏海慈生物药业有限公司 一种多西他赛的制备方法
FR2986526A1 (fr) * 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650012A (zh) * 2013-11-22 2015-05-27 天士力控股集团有限公司 一种紫杉烷类化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2687151B1 (fr) * 1992-02-07 1994-03-25 Rhone Poulenc Rorer Sa Nouveaux derives de la baccatine iii et de la desacetyl-10 baccatine iii, leur preparation et les compositions pharmaceutiques qui les contiennent.
US5440056A (en) * 1992-04-17 1995-08-08 Abbott Laboratories 9-deoxotaxane compounds

Also Published As

Publication number Publication date
SG63619A1 (en) 1999-03-30
CZ84295A3 (en) 1995-09-13
DK0663907T3 (da) 1997-02-03
FI951591L (fi) 1995-04-04
FI109791B (fi) 2002-10-15
CZ283362B6 (cs) 1998-03-18
HU223775B1 (hu) 2005-01-28
LV10858A (lv) 1995-10-20
UA43835C2 (uk) 2002-01-15
JP3014761B2 (ja) 2000-02-28
RU2116302C1 (ru) 1998-07-27
KR100297197B1 (ko) 2001-11-26
ZA937319B (en) 1994-04-22
WO1994007878A1 (fr) 1994-04-14
AU5115193A (en) 1994-04-26
LV10858B (en) 1996-06-20
FR2696459B1 (fr) 1994-11-25
SK43595A3 (en) 1995-08-09
GEP19981299B (en) 1998-05-01
NO310412B1 (no) 2001-07-02
MX9305767A (es) 1994-05-31
AU689081B2 (en) 1998-03-26
CN1087905A (zh) 1994-06-15
RU95110686A (ru) 1996-12-27
ATE147735T1 (de) 1997-02-15
TW262471B (es) 1995-11-11
LT3439B (en) 1995-10-25
FI951591A0 (fi) 1995-04-04
SK280624B6 (sk) 2000-05-16
GR3022285T3 (en) 1997-04-30
NZ256446A (en) 1996-06-25
CA2146155A1 (fr) 1994-04-14
DE69307527D1 (de) 1997-02-27
HU9500967D0 (en) 1995-06-28
LTIP1396A (en) 1995-01-31
NO951202L (no) 1995-03-29
EE03125B1 (et) 1998-10-15
EP0663907A1 (fr) 1995-07-26
FR2696459A1 (fr) 1994-04-08
CN1048983C (zh) 2000-02-02
CA2146155C (fr) 2003-03-11
JPH08501789A (ja) 1996-02-27
US5637723A (en) 1997-06-10
NO951202D0 (no) 1995-03-29
PL308306A1 (en) 1995-07-24
HUT72612A (en) 1996-05-28
PL179147B1 (pl) 2000-07-31
KR950703547A (ko) 1995-09-20
DE69307527T2 (de) 1997-05-22
EP0663907B1 (fr) 1997-01-15

Similar Documents

Publication Publication Date Title
ES2095081T3 (es) Procedimiento para la preparacion de derivados de taxano.
ES2098060T3 (es) Procedimiento para la preparacion de derivados del taxano.
ES2055119T3 (es) Procedimiento para la preparacion de derivados de la bacatina iii y de la desacetil-10 bacatina iii.
ES2090970T3 (es) Procedimiento para la preparacion de derivados del taxano.
MX9305767A (es) Procedimiento para la preparacion de derivados de taxano y los derivados de taxano asi obtenidos.
AR004087A1 (es) Derivado del acido fenilacetico, procedimientos y productos intermedios para su obtencion y las composiciones que los contienen
MX9305764A (es) Procedimiento para la preparacion de los esteres de la bacatina iii y dela 10-desacetil bacatina iii y productos obtenidos por medio del mismo.
ES8400444A1 (es) Procedimiento para la preparacion de nuevos derivados de carbapenem.
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
ES2133418T3 (es) Procedimiento para la preparacion de derivados del taxano.
FI850741L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyridobensotiazinderivat.
ES2100335T3 (es) Derivados de benzopirano y fenol para empleo como agentes inmunoestimulantes.
ES8308840A1 (es) "un procedimiento para la preparacion de derivados tetrasubstituidos del benceno".
ES8404361A1 (es) Un procedimiento para la preparacion de un derivado de cefalosporina.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2001094A6 (es) Un procedimiento para la preparacion de un derivado de guanina
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
MX9304820A (es) Derivados de 1, 4-benzodioxano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2086442T3 (es) Derivados de fluoroetilcamptotecina.
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2068497T3 (es) Derivados de urea, su produccion, y composiciones farmaceuticas que los contienen.
ES2038708T3 (es) Metodo para producir compuestos de benzotiepino(5,4-c)piridazina.
MX9300008A (es) Nucleosidos terapeuticos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 663907

Country of ref document: ES